Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jude Samulski

Showing results (71-80 of 163) with videos related to

Pageof 17
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 19, 2021
"D" matters in recombinant AAV DNA packagingJunping Zhang, Ping Guo, Yinxia Xu, et al.
Journal of Virology|May 18, 2007
Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virionsJoshua C Grieger, Jarrod S Johnson, Brittney Gurda-Whitaker, et al.
Journal of Virology|May 4, 2007
Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivoChengwen Li, Matthew Hirsch, Aravind Asokan, et al.
Journal of Virology|August 22, 2014
Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanismsMarc S Weinberg, Sarah Nicolson, Aadra P Bhatt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 14, 2011
Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primatesSteven J Gray, Valerie Matagne, Lavanya Bachaboina, et al.
Viruses|December 15, 2019
Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus VectorsZheng Chai, Xintao Zhang, Amanda Lee Dobbins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2008
Adeno-associated virus of a single-polarity DNA genome is capable of transduction in vivoXiaohuai Zhou, Xinghua Zeng, Zhenghong Fan, et al.
Journal of Virology|September 1, 2006
Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypesZhijian Wu, Aravind Asokan, Joshua C Grieger, et al.
Human Gene Therapy|January 28, 2017
Systemic and Persistent Muscle Gene Expression in Rhesus Monkeys with a Liver De-Targeted Adeno-Associated Virus VectorAlice F Tarantal, C Chang I Lee, Michele L Martinez, et al.
Journal of Virology|April 17, 2009
Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivoChengwen Li, Matt Hirsch, Nina DiPrimio, et al.
Pageof 17

Showing results (71-80 of 163) with videos related to

Sort By:
Pageof 17
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 19, 2021
"D" matters in recombinant AAV DNA packagingJunping Zhang, Ping Guo, Yinxia Xu, et al.
Journal of Virology|May 18, 2007
Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virionsJoshua C Grieger, Jarrod S Johnson, Brittney Gurda-Whitaker, et al.
Journal of Virology|May 4, 2007
Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivoChengwen Li, Matthew Hirsch, Aravind Asokan, et al.
Journal of Virology|August 22, 2014
Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanismsMarc S Weinberg, Sarah Nicolson, Aadra P Bhatt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 14, 2011
Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primatesSteven J Gray, Valerie Matagne, Lavanya Bachaboina, et al.
Viruses|December 15, 2019
Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus VectorsZheng Chai, Xintao Zhang, Amanda Lee Dobbins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2008
Adeno-associated virus of a single-polarity DNA genome is capable of transduction in vivoXiaohuai Zhou, Xinghua Zeng, Zhenghong Fan, et al.
Journal of Virology|September 1, 2006
Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypesZhijian Wu, Aravind Asokan, Joshua C Grieger, et al.
Human Gene Therapy|January 28, 2017
Systemic and Persistent Muscle Gene Expression in Rhesus Monkeys with a Liver De-Targeted Adeno-Associated Virus VectorAlice F Tarantal, C Chang I Lee, Michele L Martinez, et al.
Journal of Virology|April 17, 2009
Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivoChengwen Li, Matt Hirsch, Nina DiPrimio, et al.
Pageof 17